Literature DB >> 24637688

A highly active and negatively charged Streptococcus pyogenes lysin with a rare D-alanyl-L-alanine endopeptidase activity protects mice against streptococcal bacteremia.

Rolf Lood1, Assaf Raz1, Henrik Molina2, Chad W Euler1, Vincent A Fischetti3.   

Abstract

Bacteriophage endolysins have shown great efficacy in killing Gram-positive bacteria. PlyC, a group C streptococcal phage lysin, represents the most efficient lysin characterized to date, with a remarkably high specificity against different streptococcal species, including the important pathogen Streptococcus pyogenes. However, PlyC is a unique lysin, in terms of both its high activity and structure (two distinct subunits). We sought to discover and characterize a phage lysin active against S. pyogenes with an endolysin architecture distinct from that of PlyC to determine if it relies on the same mechanism of action as PlyC. In this study, we identified and characterized an endolysin, termed PlyPy (phage lysin from S. pyogenes), from a prophage infecting S. pyogenes. By in silico analysis, PlyPy was found to have a molecular mass of 27.8 kDa and a pI of 4.16. It was active against a majority of group A streptococci and displayed high levels of activity as well as binding specificity against group B and C streptococci, while it was less efficient against other streptococcal species. PlyPy showed the highest activity at neutral pH in the presence of calcium and NaCl. Surprisingly, its activity was not affected by the presence of the group A-specific carbohydrate, while the activity of PlyC was partly inhibited. Additionally, PlyPy was active in vivo and could rescue mice from systemic bacteremia. Finally, we developed a novel method to determine the peptidoglycan bond cleaved by lysins and concluded that PlyPy exhibits a rare d-alanyl-l-alanine endopeptidase activity. PlyPy thus represents the first lysin characterized from Streptococcus pyogenes and has a mechanism of action distinct from that of PlyC.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24637688      PMCID: PMC4068442          DOI: 10.1128/AAC.00115-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  63 in total

1.  LysA2, the Lactobacillus casei bacteriophage A2 lysin is an endopeptidase active on a wide spectrum of lactic acid bacteria.

Authors:  Pedro Ribelles; Isabel Rodríguez; Juan Evaristo Suárez
Journal:  Appl Microbiol Biotechnol       Date:  2011-09-28       Impact factor: 4.813

Review 2.  Prophage genomics.

Authors:  Carlos Canchaya; Caroline Proux; Ghislain Fournous; Anne Bruttin; Harald Brüssow
Journal:  Microbiol Mol Biol Rev       Date:  2003-06       Impact factor: 11.056

3.  Isolation and characterization of the cell-associated region of group A streptococcal M6 protein.

Authors:  V Pancholi; V A Fischetti
Journal:  J Bacteriol       Date:  1988-06       Impact factor: 3.490

4.  Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase.

Authors:  J M Loeffler; D Nelson; V A Fischetti
Journal:  Science       Date:  2001-12-07       Impact factor: 47.728

Review 5.  Bacteriophage lysins as effective antibacterials.

Authors:  Vincent A Fischetti
Journal:  Curr Opin Microbiol       Date:  2008-10-14       Impact factor: 7.934

6.  Prophage induction and expression of prophage-encoded virulence factors in group A Streptococcus serotype M3 strain MGAS315.

Authors:  David J Banks; Benfang Lei; James M Musser
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

7.  Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips.

Authors:  Juri Rappsilber; Matthias Mann; Yasushi Ishihama
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

8.  Use of 4-sulfophenyl isothiocyanate labeling and mass spectrometry to determine the site of action of the streptococcolytic peptidoglycan hydrolase zoocin A.

Authors:  Shaw R Gargis; Harry E Heath; Lucie S Heath; Paul A Leblanc; Robin S Simmonds; Brian D Abbott; Russell Timkovich; Gary L Sloan
Journal:  Appl Environ Microbiol       Date:  2008-10-31       Impact factor: 4.792

9.  Novel bacteriophage lysin with broad lytic activity protects against mixed infection by Streptococcus pyogenes and methicillin-resistant Staphylococcus aureus.

Authors:  Daniel B Gilmer; Jonathan E Schmitz; Chad W Euler; Vincent A Fischetti
Journal:  Antimicrob Agents Chemother       Date:  2013-04-09       Impact factor: 5.191

10.  A bacteriolytic agent that detects and kills Bacillus anthracis.

Authors:  Raymond Schuch; Daniel Nelson; Vincent A Fischetti
Journal:  Nature       Date:  2002-08-22       Impact factor: 49.962

View more
  22 in total

1.  Bacteriocin protein BacL1 of Enterococcus faecalis targets cell division loci and specifically recognizes L-Ala2-cross-bridged peptidoglycan.

Authors:  Jun Kurushima; Daisuke Nakane; Takayuki Nishizaka; Haruyoshi Tomita
Journal:  J Bacteriol       Date:  2014-11-03       Impact factor: 3.490

Review 2.  Recombinant Endolysins as Potential Therapeutics against Antibiotic-Resistant Staphylococcus aureus: Current Status of Research and Novel Delivery Strategies.

Authors:  Hamed Haddad Kashani; Mathias Schmelcher; Hamed Sabzalipoor; Elahe Seyed Hosseini; Rezvan Moniri
Journal:  Clin Microbiol Rev       Date:  2017-11-29       Impact factor: 26.132

3.  Using a Novel Lysin To Help Control Clostridium difficile Infections.

Authors:  Qiong Wang; Chad W Euler; Aurelia Delaune; Vincent A Fischetti
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

4.  Novel phage lysin capable of killing the multidrug-resistant gram-negative bacterium Acinetobacter baumannii in a mouse bacteremia model.

Authors:  Rolf Lood; Benjamin Y Winer; Adam J Pelzek; Roberto Diez-Martinez; Mya Thandar; Chad W Euler; Raymond Schuch; Vincent A Fischetti
Journal:  Antimicrob Agents Chemother       Date:  2015-01-20       Impact factor: 5.191

5.  Prophage lysin Ply30 protects mice from Streptococcus suis and Streptococcus equi subsp. zooepidemicus infections.

Authors:  Fang Tang; Dezhi Li; Haojin Wang; Zhe Ma; Chengping Lu; Jianjun Dai
Journal:  Appl Environ Microbiol       Date:  2015-08-07       Impact factor: 4.792

6.  The essential protein for bacterial flagella formation FlgJ functions as a β-N-acetylglucosaminidase.

Authors:  Francesca A Herlihey; Patrick J Moynihan; Anthony J Clarke
Journal:  J Biol Chem       Date:  2014-09-23       Impact factor: 5.157

Review 7.  Antimicrobial bacteriophage-derived proteins and therapeutic applications.

Authors:  Dwayne R Roach; David M Donovan
Journal:  Bacteriophage       Date:  2015-06-23

8.  The molecular mechanism of N-acetylglucosamine side-chain attachment to the Lancefield group A carbohydrate in Streptococcus pyogenes.

Authors:  Jeffrey S Rush; Rebecca J Edgar; Pan Deng; Jing Chen; Haining Zhu; Nina M van Sorge; Andrew J Morris; Konstantin V Korotkov; Natalia Korotkova
Journal:  J Biol Chem       Date:  2017-10-11       Impact factor: 5.157

9.  Alternative therapeutics for self-limiting infections-An indirect approach to the antibiotic resistance challenge.

Authors:  Kristofer Wollein Waldetoft; Sam P Brown
Journal:  PLoS Biol       Date:  2017-12-28       Impact factor: 8.029

10.  Molecular basis for recognition of the Group A Carbohydrate backbone by the PlyC streptococcal bacteriophage endolysin.

Authors:  Harley King; Sowmya Ajay Castro; Amol Arunrao Pohane; Cynthia M Scholte; Vincent A Fischetti; Natalia Korotkova; Daniel C Nelson; Helge C Dorfmueller
Journal:  Biochem J       Date:  2021-06-25       Impact factor: 3.766

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.